JAZZ  valuation analysis

Name: Jazz Pharmaceuticals plc
Description: Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Nov 09, 2021
Market cap: $7.83B (576th)
Sales(TTM): $2.86B (665th)
Earnings(TTM): -$160.90M (1315th)

FFER: 1.24 (why)
Actual price: $127.70
FFEThis is Jazz Pharmaceuticals plc's the estimated price. FFEs are the denominator of the FFER ratio.: $102.82
Quantile: JAZZ is expensive given its fundamentals.
Prices as of EOD 2021-12-22
Price & Estimates
Sales & Earnings history (TTM)
  • Jazz Pharmaceuticals plc's earnings decreased from $179.19M to -$160.90M in the last year.
Earnings / MarketCap
Jazz Pharmaceuticals plc
"Biotechnology" industry
Sales / MarketCap
Jazz Pharmaceuticals plc
"Biotechnology" industry
Book / MarketCap
Jazz Pharmaceuticals plc
"Biotechnology" industry
Equity / Assets
Jazz Pharmaceuticals plc
"Biotechnology" industry